Jiuzhitang Co., Ltd. (SHE:000989)

Market Cap	7.46B
Revenue (ttm)	2.10B
Net Income (ttm)	188.15M
Shares Out	846.28M
EPS (ttm)	0.22
PE Ratio	39.74
Forward PE	n/a
Dividend	0.30 (3.43%)
Ex-Dividend Date	May 8, 2025

Volume	12,197,453
Average Volume	45,428,587
Open	9.90
Previous Close	8.74
Day's Range	8.74 - 9.90
52-Week Range	6.10 - 10.58
Beta	0.42
RSI	45.28
Earnings Date	Aug 8, 2025

About Jiuzhitang

Jiuzhitang Co., Ltd. provides traditional Chinese, chemical, biological, and health medicine products in China. The company offers Shuxuetong injections, Angong Niuhuang pills, Gastrodia Gouteng granules, Danxi granules, and Compound Jiangzhi tablets for cardiovascular and neurological treatment; Nudehua Zizhu tablets, Xiaojin pills, Guizhi Fuling pills, Buxue Shengru granules, and Zhixue Analgesic capsules for the treatment in gynecology; Houyan pills for ear, nose, and throat (ENT) diseases; Jianwei Yuyang tablets for digestion; and prescript...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 3,689
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000989

Financial Performance

In 2024, Jiuzhitang's revenue was 2.37 billion, a decrease of -19.91% compared to the previous year's 2.96 billion. Earnings were 216.20 million, a decrease of -27.31%.